About Cagent Vascular
Cagent Vascular is a private company based in Wayne, Pennsylvania. It has reported $73,017,934 raised in six offerings on Form D since June 2014. Its chief executive is Brian Walsh.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 18, 2026 | Jun 5, 2026 | $24,477,945of $40.9M target | 51 | $479K | EquityRule 506(b) | Form D ↗ |
| Jan 30, 2024 | Feb 14, 2024 | $28,741,501of $30.2M target | 26 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Apr 21, 2023 | May 4, 2023 | $7,248,488of $11.0M target | 41 | $176K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 15, 2021 | Jun 25, 2021 | $9,500,000fully sold | 11 | $863K | EquityRule 506(b) | Form D ↗ |
| Jul 11, 2017 | Aug 4, 2017amended May 14, 2018 | $3,000,000of $12.0M target | 31 | $96,774 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 15, 2014 | Jun 26, 2014 | $50,000of $6.0M target | 2 | $25,000 | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $73,017,934 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cagent Vascular's Form D filed Jun 5, 2026.
Earlier filings also listed Dennis McGrath (executive officer, last listed Feb 2024), Carol Burns (ceo and director, last listed Feb 2024), Bruce Blumfield (director, last listed Feb 2024), Peter Schneider (director, last listed May 2023), Mike Markert (director, last listed May 2023), Greg Fredde (director, last listed May 2023), Fred Lampropoulos (director, last listed Jun 2021) and Robert Giasolli (director, last listed May 2018).